The aim of the clinical study is: 1. to examine the association between postoperative endothelial function, indirectly measured by reactive hyperemia index, and major adverse cardiovascular events including myocardial injury and cardiac death within 30, 90 and 365 days of acute abdominal surgery. 2. to examine the association between postoperative endothelial function, indirectly measured by reactive hyperemia index, and non-cardiovascular complications including non-cardiac death within 30, 90 and 365 days of acute abdominal surgery. 3. to examine the importance of the postoperative blood glucose level and the pulmonary function for postoperative complications and death within 30, 90 and 365 days of acute abdominal surgery. 4. to examine the association between postoperative endothelial function, pulmonary function and blood glucose level 5. the qualitative part of the study will examine the postoperative subjective symptoms including acute and chronic pain, quality of recovery and functional status, depressive thoughts and post-traumatic stress disorder.
Study Type
OBSERVATIONAL
Enrollment
224
Acute abdominal surgery within 72 hours of admission to the department of surgery
Department of Surgery, Zealand University Hospital, Koge
Køge, Denmark
The change in reactive hyperemia index assessed by EndoPat
Time frame: The change from 4-24 hours to between day 3 and 5 after surgery
Major adverse cardiovascular events
* Cardiovascular death * Myocardial injury within postoperative day 3 (definition: peak plasma cardiac troponin-I ≥ 45ng/L (99th percentile URL, 10% CV at 40ng/L)) * Acute coronary syndrome (unstable angina pectoris, NSTEMI, STEMI) * Congestive heart failure * Stroke * Nonfatal cardiac arrest * New clinically important cardiac arrhythmia * Coronary revascularization procedure (PCI or CABG) * Sudden unexpected death
Time frame: Within 365 days of surgery
Postoperative non-cardiovascular complications
Non-cardiovascular death, sepsis, pneumonia, respiratory failure, surgical complications (min. Clavien-Dindo stage 3), Any non-cardiovascular life-threatening complication (Clavien-Dindo stage 4).
Time frame: Within 365 days of surgery
Nitric oxide biomarkers
Time frame: 4-24 hours after surgery and between postoperative day 3-5
Reactive hyperemia index assessed by EndoPat
Time frame: 4-24 hours after surgery
Reactive hyperemia index assessed by EndoPat
Time frame: between day 3 and 5 after surgery
Blood Glucose level
Time frame: Postoperative day 1 - 7 (or until discharge)
Pulmonary function
Time frame: Postoperative day 1 - 7 (or until discharge)
Readmission
Time frame: Readmissions within 1 year of discharge
Lengths of stay
Time frame: Lengths of stay from the operation day to discharge, on average 14 days.
Lengths of stay in the intensive care unit
Time frame: Lengths of stay from the operation day to discharge from hospital, on average 14 days.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.